Siren secures strategic funding for its socks that detect diabetic foot ulcers

Siren raises $9.5M for DFU-detecting socks, securing $43M total.

: Siren has secured $9.5 million, with $8 million from Mölnlycke Health Care, to advance its diabetic foot ulcer prevention socks. Ran Ma, who created the product after studying burn victims and war veterans, claims it reduces DFU risks significantly. Siren has raised a total of $43 million, with contributors like Khosla Ventures and Founders Fund.

Siren has announced a strategic funding round totaling $9.5 million, propelled by an $8 million investment from Mölnlycke Health Care, for its innovative diabetic foot ulcer prevention product, Siren Socks. To date, the company has amassed $43 million in funding, enhancing its capability to revolutionize diabetes care with technology.

The socks use sensors to monitor a patient’s foot temperature, detecting hotspots that may signify ulcer development. This proactive approach can potentially lower the risk of developing diabetic foot ulcers by up to 68% and reduce amputation risks by 83%, creating significant value in diabetic care.

Founder Ran Ma, who has a background in biomedical engineering from Johns Hopkins and Northwestern University, initially developed prototypes using simple materials and a creative assembly process. Siren's success in raising capital, highlighted by support from notable investors such as Khosla Ventures and the recent strategic backing from Mölnlycke, underscores its promising position in the market against competitors like Podimetrics and Orpyx.

DiabetesFoot UlcersMedTech